2 results
Approved WMORecruiting
To assess the efficacy and safety of LCI699 in CD patients
BioXmark liquid fiducial to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial
To test the feasibility and accuracy of BioXmark fiducial markers for IGRT based rectal tumor boosting.